Production of C5a by ASP, a serine protease released from Aeromonas sobria

Journal of Immunology

Volumn 181, Issue 5, 2008, Pages 3602-3608

  Nitta, Hidetoshi ^a   Imamura, Takahisa ^a   Wada, Yoshihiro ^a   Irie, Atsushi ^a   Kobayashi, Hidetomo ^b   Okamoto, Keinosuke ^c   Baba, Hideo ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

^b HIROSHIMA INTERNATIONAL UNIVERSITY   (Japan)

^c OKAYAMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AEROMONAS SOBRIA SERINE PROTEINASE; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C5 INHIBITOR; COMPLEMENT COMPONENT C5A; HISTAMINE H1 RECEPTOR ANTAGONIST; SERINE PROTEINASE; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG; BACTERIAL PROTEIN; COMPLEMENT COMPONENT C5;

AEROMONAS SOBRIA; ARTICLE; CELL MIGRATION; ENZYME RELEASE; GUINEA PIG; HUMAN; IMMUNOBLOTTING; IN VIVO STUDY; NEUTROPHIL; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS; AEROMONAS; ANIMAL; CAPILLARY PERMEABILITY; ENZYMOLOGY; GRAM NEGATIVE INFECTION; METABOLISM; PATHOGENICITY; PATHOLOGY;

AEROMONAS; ANIMALS; BACTERIAL PROTEINS; CAPILLARY PERMEABILITY; CHEMOTAXIS, LEUKOCYTE; COMPLEMENT C5; COMPLEMENT C5A; GRAM-NEGATIVE BACTERIAL INFECTIONS; GUINEA PIGS; HUMANS; NEUTROPHILS; SERINE ENDOPEPTIDASES;

EID: 51549094617     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.181.5.3602     Document Type: Article

References (46)

1. Janda, J. M., and R. Brenden. 1987. Importance of Aeromonas sobria in Aeromonas bacteremia. J. Infect. Dis. 155: 589-591.
2. Farraye, F. A., M. A. Peppercom, R. S. Ciano, and W. N. Kavesh. 1989. Segmental colitis associated with Aeromonas hydrophila. Am. J. Gastroenterol. 84: 436-438.
3. Janda, J. M., and S. L. Abbott. 1998. Evolving concepts regarding the genus Aeromonas: an expanding panorama of species, disease presentations, and unanswered questions. Clin. Infect. Dis. 27: 332-344.
4. Deutsch, S. F., and W. Wedzina. 1997. Aeromonas sobria-associated left-sided segmental colitis. Am. J. Gastroenterol. 92: 2104-2106.
5. Janda, J. M., S. L. Abbott, and R. A. Brenden. 1997. Overview of the etiology of wound infections with particular emphasis on community-acquired illnesses. Eur. J. Clin. Microbiol. Infect. Dis. 16: 189-201.
6. Gold, W. L., and I. E. Salit. 1993. Aeromonas hydrophila infections of skin and soft tissue: report of 11 cases and review. Clin. Infect. Dis. 16: 69-74.
7. Semel, J. D., and G. Trenholme. 1990. Aeromonas hydrophila water-associated traumatic wound infections: a review. J. Trauma 30: 324-327.
8. Janda, J. M. 1991. Recent advances in the study of the taxonomy, pathogenicity, and infectious syndromes associated with the genus Aeromonas. Clin. Microbiol. Rev. 4: 397-410.
9. Imamara, T., H. Kobayashi, R. Khan, H. Nitta, and K. Okamoto. 2006. Induction of vascular leakage and blood pressure lowering through kinin release by a serine protease from Aeromonas sobria. J. Immunol. 177: 8723-8729.
10. Janda, J. M., M. Reitano, and E. J. Bottone. 1984. Biotyping of Aeromonas isolates as a correlate to delineating a species-associated disease spectrum. J. Clin. Microbiol. 19: 44-47.
11. Daily, O. P., S. W. Joseph, J. C. Coolbaugh, R. I. Walker, B. R. Merrell, D. M. Rollins, R. J. Seidler, R. R. Colwell, and C. R. Lissner. 1981. Association of Aeromonas sobria with human infection. J. Clin. Microbiol. 13: 769-777.
12. Nitta, H., H. Kobayashi, A. Irie, H. Baba, K. Okamoto, and T. Imamura. 2007. Activation of prothrombin by ASP, a serine protease released from Aeromonas sobria. FEBS Lett. 581: 5935-5939.
13. Aird, W. C. 2005. Sepsis and coagulation. Crit. Care Clin. 21: 417-431.
14. DiScipio, R. G., C. A. Smith, H. J. Muller-Eberhard, and T. E. Hugli. 1983. The activation of human complement component C5 by a fluid phase C5 convertase. J. Biol. Chem. 258: 10629-10636. (Pubitemid 14244323)
15. Marder, S. R., D. E. Chenoweth, I. M. Goldstein, and H. D. Perez. 1985. Chemotactic responses of human peripheral blood monocytes to the complement-derived peptides C5a and C5a des Arg. J. Immunol. 134: 3325-3331.
16. Goldstein, I. M., and G. Weissmann. 1974. Generation of C5-derived lysosomal enzyme releasing activity (C5a) by lysates of leukocyte lysosomes. J. Immunol. 113: 1583-1588.
17. Sacks, T., C. F. Moldow, P. R. Craddock, T. K. Bowers, and H. S. Jacob. 1978. Oxygen radicals mediate endothelial cell damage by complement-stimulated granulocytes: an in vitro model of immune vascular damage. J. Clin. Invest. 61: 1161-1167. (Pubitemid 8324140)
18. Mollnes, T. E., O. L. Brekke, M. Fung, H. Fure, D. Christiansen, G. Bergseth, V. Videm, K. T. Lappegård, J. Köhl, and J. D. Lambris. 2002. Essential role of the C5a receptor in E. coli induced oxidative burst and phagocytosis revealed by a novel lepirudin-based human whole blood model of inflammation. Blood 100: 1869-1877.
19. Kikuchi, Y., and A. P. Kaplan. 2002. A role for C5a in augmenting IgG-dependent histamine release from basophils in chronic urticaria. J. Allergy Clin. Immunol. 109: 114-118. (Pubitemid 34112139)
20. Konteatis, Z. D., S. J. Siciliano, G. V. Riper, C. J. Molineaux, S. Pandya, P. Fischer, H. Rosen, R. A. Mumford, and M. S. Springer. 1994. Development of C5a receptor antagonists: differential loss of functional responses. J. Immunol. 153: 4200-4205.
21. Okamoto, K., T. Nomura, M. Hamada, T. Fukuda, Y. Noguchi, and Y. Fujii. 2000. Production of serine protease of Aeromonas sobria is controlled by the protein encoded by the gene lying adjacent to the 3′ end of the protease gene. Microbiol. Immunol. 44: 787-798. (Pubitemid 30745107)
22. Fernandez, H. N., P. M. Henson, A. Otani, and T. E. Hugli. 1978. Primary structural analysis of the polypeptide portion of human C5a anaphylatoxin: polypeptide sequence determination and assignment of the oligosaccharide attachment site in C5a. J. Immunol. 120: 109-117.
23. Matthews, J. B., H. J. Wright, A. Roberts, P. R. Cooper, and I. L. C. Chapple. 2007. Hyperactivity and reactivity of peripheral blood neutrophils in chronic periodontitis. Clin. Exp. Immunol. 147: 255-264.
24. Udaka, K., Y. Takeuchi, and H. Z. Movat. 1970. Simple method for quantitation of enhanced vascular permeability. Proc. Soc. Exp. Biol. Med. 133: 1384-1387.
25. Halkier, T. 1991. Mechanisms in Blood Coagulation, Fibrinolysis and the Complement System. Cambridge University Press, Cambridge, U.K.
26. Reed, L. R., J. A. Ember, D. S. Herdman, R. G. DiScipio, T. E. Hugli, and I. Gigli. 1995. The extracellular neutral cysteine proteinase of Entamoeba histolytica degrades anaphylatoxins C3a and C5a. J. Immunol. 155: 266-274.
27. Jagels, M. A., J. Travis, J. Potempa, R. Pike, and T. E. Hugli. 1996. Proteolytic inactivation of the leukocyte C5a receptor by proteinases derived from Porphyromonas gingivalis. Infect. Immun. 64: 1984-1991.
28. Reid, K. B., and R. R. Porter. 1981. The proteolytic activation systems of complement. Annu. Rev. Biochem. 50: 433-464.
29. Müller-Eberhard, H. J. 1986. The membrane attack complex of complement. Annu. Rev. Immunol. 4: 503-528.
30. Fernandez, H. N., and T. E. Hugli. 1978. Primary structural analysis of the polypeptide portion of human C5a anaphylatoxin: polypeptide sequence determination and assignment of the oligosaccharide attachment site in C5a. J. Biol. Chem. 253: 6955-6964.
31. Kobayashi, H., E. Takahashi, K. Oguma, Y. Fujii, H. Yamanaka, T. Negishi, S. Arimoto-Kobayashi, T. Tsuji, and K. Okamoto. 2006. Cleavage specificity of the serine protease of Aeromonas sobria, a member of the kexin family of subtilases. FEMS Microb. Lett. 256: 165-170.
32. de Bruijn, M. H. L., and G. H. Fey. 1985. Human complement component C3: cDNA coding sequence and derived primary structure. Proc. Natl. Acad. Sci. USA 82: 708-712. (Pubitemid 15142747)
33. Maruo, K., T. Akaike, T. Ono, T. Okamoto, and H. Maeda. 1997. Generation of anaphylatoxins through proteolytic processing of C3 and C5 by house dust mite protease. J. Allergy Clin. Immunol. 100: 253-260. (Pubitemid 27349869)
34. Wingrove, J. A., R. G. DiScipio, Z. Chen, J. Potempa, J. Travis, and T. E. Hugli. 1992. Activation of complement components C3 and C5 by a cysteine proteinase (gingipain-1) from Porphyromonas (Bacteroides) gingivalis. J. Biol. Chem. 267: 18902-18907.
35. DiScipio, R. G., P. J. Daffern, M. Kawahara, R. Pike, J. Travis, and T. E. Hugli. 1996. Cleavage of human complement component C5 by cysteine proteinases from Porphyromonas gingivalis: prior oxidation of C5 augments proteinase digestion of C5. Immunology 87: 660-667.
36. Wöhrl. S., W. Hemmer, M. Focke, K. Rappersberger, and R. Jarisch. 2004. Histamine intolerance-like symptoms in healthy volunteers after oral provocation with liquid histamine. Allergy Asthma Proc. 25: 305-311. (Pubitemid 39534396)
37. Feng, B. S., S. H. He, P. Y. Zheng, L. Wu, and P. C. Yang. 2007. Mast cells play a crucial role in Staphylococcus aureus peptidoglycan-induced diarrhea. Am. J. Pathol. 171: 537-547.
38. Janda, J. M., and P. S. Duffey. 1988. Mesophilic aeromonads in human disease: current taxonomy, laboratory identification, and infectious disease spectrum. Rev. Infect. Dis. 10: 980-997.
39. Czermak, B. J., M. Breckwoldt, Z. B. Ravage, M. Huber-Lang, H. Schmal, N. M. Bless, H. P. Friedl, and P. A. Ward. 1999. Mechanisms of enhanced lung injury during sepsis. Am. J. Pathol. 154: 1047-1055.
40. Fittschen, C., R. A. Sandhaus, G. S. Worthen, and P. M. Henson. 1988. Bacterial lipopolysaccharide enhances chemoattractant-induced elastase secretion by human neutrophils. J. Leukocyte Biol. 43: 547-556. (Pubitemid 18169738)
41. Muhlfelder, T. W., J. Niemetz, D. Kreutzer, D. Beebe, P. A. Ward, and S. I. Rosenfeld. 1979. C5 chemotactic fragment induces leukocyte production of tissue factor activity: a link between complement and coagulation. J. Clin. Invest. 63: 147-150.
42. Ikeda, K., K. Nagasawa, T. Horiuchi, T. Tsuru, H. Nishizaka, and Y. Niho. 1997. C5a induces tissue factor activity on endothelial cells. Thromb. Haemost. 77: 394-398. (Pubitemid 27084936)
43. Levi, M., and H. Ten Cate. 1999. Disseminated intravascular coagulation. N. Engl. J. Med. 341: 586-592.
44. Huber-Lang, M. S., E. M. Younkin, J. V. Sarma, S. R. McGuire, K. T. Lu, R. F. Guo, V. A. Padgaonkar, J. T. Curnutte, R. Erickson, and P. A. Ward. 2002. Complement-induced impairment of innate immunity during sepsis. J. Immunol. 169: 3223-3231.
45. Guo, R. F., N. C. Riedemann, K. D. Bernacki, V. J. Sarma, I. J. Laudes, J. S. Reuben, E. M. Younkin, T. A. Neff, J. D. Paulauskis, F. S. Zetoune, and P. A. Ward. 2003. Neutrophil C5a receptor and the outcome in a rat model of sepsis. FASEB J. 13: 1889-1891.
46. Nakae, H., S. Endo, K. Inada, T. Takakuwa, T. Kasai, and M. Yoshida. 1994. Serum complement levels and severity of sepsis. Res. Commun. Chem. Pathol. Pharmacol. 84: 189-195. (Pubitemid 24174432)